Register of
Medicinal Products

Product class: Medicinal product with marketing authorization
Medicinal product class: Human medicine
Name of medicinal product: BIMATOPROST/TIMOLOL MYLAN
Active substances:
Timolol+Bimatoprost
Estonian, English, Latin
ATC code: S01ED82
Dosage form: eye drops, solution
Strength: 5mg+0,3mg 1ml
Legal status for supply*: Subject to medicinal prescription
Summary of product characteristics (SPC):  (last updated April 5, 2022)
Package information leaflet (PIL): EST  (last updated December 16, 2021)
Labelling:  (last updated September 28, 2021)
Indication: Reduction of intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.
Safety features: Yes
Marketing authorization holder: Mylan Pharmaceuticals Limited 
Marketing authorization number: 947317 
Marketing authorization issued on: September 12, 2017 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Decentralised 
Assessment report:  (last updated September 12, 2017) 
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported Additional information
1720178  BIMATOPROST/TIMOLOL MYLAN  eye drops, solution  5mg +0,3mg 1ml 3ml 1TK  Prescription  100% 50%  8,40  04.11.2022   
1720189  BIMATOPROST/TIMOLOL MYLAN  eye drops, solution  5mg +0,3mg 1ml 3ml 3TK  Prescription         
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere